Antonio Solis Leal Email and Phone Number

I worked on a cutting-edge research project funded by Ionis Pharmaceuticals, aimed at exploring novel therapeutic strategies for Alzheimer's disease. The primary focus of this project was on tau mRNA replacement therapy, a promising approach to target the molecular mechanisms underlying Alzheimer's pathology. My role in this research involved multiple technical and experimental responsibilities.One of my key tasks was the design and construction of plasmids tailored to the specific needs of tau mRNA replacement. This involved meticulous planning and execution, ensuring that the plasmids were engineered to facilitate effective expression and functionality in the target cells. Additionally, I performed RNA extraction from cell lines and yeast, a critical step in the process of verifying the success of the mRNA replacement and assessing the biological responses to the intervention.Throughout the project, I utilized a range of molecular biology techniques, such as transfection and electrophoresis, to introduce and monitor the plasmid constructs in various experimental systems. My work also included site-directed mutagenesis to introduce specific changes into the plasmids, optimizing their effectiveness in the context of tau protein expression. These experimental tasks were vital in advancing the understanding of how tau mRNA replacement could potentially alleviate or modify the progression of Alzheimer's disease.Beyond the technical aspects, I collaborated closely with other researchers at the university, contributing to data analysis and interpretation, as well as the preparation of reports and presentations. This project not only advanced knowledge in the field of Alzheimer's research but also provided valuable insights into the potential for mRNA-based therapies as a future treatment strategy.

My research focused on advancing virology, particularly simian immunodeficiency virus (SIV) and its parallels to HIV. I contributed to projects aimed at understanding viral reservoirs in non-human primates treated with antiretroviral therapy (ART) and explored strategies to eliminate these reservoirs, a significant challenge in curing HIV.One key area of my work was the "Shock and Kill" strategy, where latency reversal agents (LRAs) were used to reactivate and eradicate latent viral reservoirs. I led the design and execution of experimental protocols, managed viral vector work, and oversaw the administration of treatments to non-human primates. I performed detailed analyses of tissue and organ samples using techniques like PCR, Q-RT-PCR, and flow cytometry to assess viral load and immune responses.In another project, I applied CRISPR/Cas9 gene-editing technology delivered through adenoviral vectors to target and remove SIV proviruses from infected central nervous system (CNS) cells. This involved planning gene-editing strategies, collaborating with other research teams, and handling CNS tissue samples with precision.Beyond the lab, I was responsible for data analysis and interpretation, contributing to high-quality reports and scientific publications. My research played a key role in advancing our understanding of viral reservoirs, with findings presented at conferences and collaborative meetings.I also participated in a project investigating the neurocognitive effects of methamphetamine use in SIV-infected, ART-treated rhesus macaques, shedding light on the relationship between drug abuse, viral infection, and cognitive decline.My work at the Texas Biomedical Research Institute advanced the search for a functional cure for HIV/SIV, and gave me valuable experience in experimental virology and gene-editing technologies.

I was engaged in molecular biology research, focusing on cutting-edge techniques for studying viruses. My work primarily involved the design, construction, and manipulation of plasmids for protein expression, a key step in the production of viral proteins for further study. This role required a strong understanding of molecular cloning, where I gained experience in manipulating DNA to create constructs used in various experiments.I also contributed to the field of gene expression analysis by utilizing techniques such as PCR and quantitative RT-PCR (Q-RT-PCR). These tools allowed me to measure and analyze the expression of genes involved in viral replication and host immune response. I conducted RNA extraction from various biological samples, such as cell lines and yeast, and optimized protocols for in vitro transcription to produce RNA molecules for further experiments.In addition to my molecular biology work, I applied advanced techniques such as site-directed mutagenesis to introduce specific changes into DNA sequences, which were crucial for understanding protein function and virus-host interactions. Transfection techniques were another critical aspect of my role, enabling me to introduce foreign DNA into mammalian cells to study protein production and viral behavior.

At Ross Southern Biolabs, I was responsible for developing and producing veterinary products, focusing on viral and protozoan species for diagnostic purposes. My work involved generating innovative ideas that could be applied to the creation of new veterinary solutions, which required both creativity and technical laboratory skills. I played a key role in producing and processing viral and protozoan species, ensuring their viability for use in diagnostic tests.I also developed protocols for studies using Luminex equipment, which allows for the detection of multiple analytes in a single sample. This required a deep understanding of assay design and optimization to ensure accurate results. In addition to my laboratory duties, I created standard operating procedures (SOPs) to document the production processes, ensuring they could be replicated efficiently by other team members.My responsibilities included reporting production progress, where I communicated challenges and solutions to maintain timelines. I contributed to writing a scientific manuscript, analyzing data, interpreting results, and clearly presenting findings for publication.Additionally, I assisted in developing the company’s website, helping to communicate the scientific and technical aspects of the products to a wider audience. I also translated manuals and the company’s website from Spanish to English, enhancing the product’s accessibility to international markets.This role provided me with valuable experience in scientific research, product development, project management, and technical writing, blending my laboratory expertise with communication and problem-solving skills to support the company's objectives.

I played a multifaceted role, contributing to both scientific and business-related activities. My primary responsibility was to conduct the experimental phase of a novel clinical technique, which involved processing human samples for laboratory testing. This required meticulous attention to detail and a deep understanding of laboratory protocols, ensuring the accuracy and reliability of the data collected. My hands-on experience with sample handling and laboratory testing was crucial in validating the new technique, which aimed to enhance clinical diagnostics.In addition to my laboratory work, I assisted in the development and refinement of a scientific article detailing the product, where I collaborated with senior researchers in writing, editing, and preparing the manuscript for publication. This involved analyzing data, interpreting results, and presenting the findings in a clear and compelling manner, ensuring the product's clinical potential was effectively communicated to the scientific community.I also contributed to the company’s outreach efforts by helping to develop a website for the product, aiming to make complex scientific information accessible to both professional and general audiences. Furthermore, I leveraged my bilingual skills by translating manuals and the company’s official website from Spanish to English, helping expand Biomedal’s reach to international markets.This position allowed me to gain experience in both research and product development while also enhancing my communication and project management skills. My contributions supported the advancement of a clinically relevant product and helped bridge the gap between scientific innovation and market application, demonstrating my ability to work across multiple domains in a dynamic biotech environment.